ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) (Q3673447): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) | |||
Revision as of 10:36, 18 November 2021
Project Q3673447 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) |
Project Q3673447 in France |
Statements
23,500.00 Euro
0 references
47,000.0 Euro
0 references
50.0 percent
0 references
1 September 2014
0 references
28 February 2019
0 references
EPA INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MEDICALE
0 references
75654
0 references
Identifiers
15P05051
0 references